Circa Group (Norway) Today
| CIRCA Stock | NOK 0.64 0.04 6.67% |
Performance8 of 100
| Odds Of DistressOver 57
|
Circa Group is selling at 0.64 as of the 29th of November 2024; that is 6.67 percent up since the beginning of the trading day. The stock's open price was 0.6. Circa Group has over 57 % chance of experiencing financial distress in the next 2 years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Circa Group AS are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of October 2024 and ending today, the 29th of November 2024. Click here to learn more.
Circa Group AS, a biotech company, engages in producing bio-based chemicals in Australia, France, the United Kingdom, Belgium, and Norway. The company was founded in 2006 and is headquartered in Oslo, Norway. CIRCA GROUP is traded on Oslo Stock Exchange in Norway. The company has 121.78 M outstanding shares. More on Circa Group AS
Moving against Circa Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Circa Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Circa Group's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Circa Group or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Circa Group AS (CIRCA) is traded on Oslo Stock Exchange in Norway and employs 14 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 730.68 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Circa Group's market, we take the total number of its shares issued and multiply it by Circa Group's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Circa Group AS operates under Healthcare sector and is part of Biotechnology industry. The entity has 121.78 M outstanding shares.
Circa Group AS has accumulated about 44.42 M in cash with (6.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.34.
Check Circa Group Probability Of Bankruptcy
Ownership AllocationCirca Group holds a total of 121.78 Million outstanding shares. Circa Group AS retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Circa Ownership Details
Circa Group AS Risk Profiles
Although Circa Group's alpha and beta are two of the key measurements used to evaluate Circa Group's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.46 | |||
| Semi Deviation | 4.91 | |||
| Standard Deviation | 8.79 | |||
| Variance | 77.18 |
Circa Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Circa Group without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
| All Next | Launch Module |
Circa Group Corporate Management
Elected by the shareholders, the Circa Group's board of directors comprises two types of representatives: Circa Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Circa. The board's role is to monitor Circa Group's management team and ensure that shareholders' interests are well served. Circa Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Circa Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Philipp Morgenthaler | Global Manufacturing | Profile | |
| Nick Smith | Head Commercialisation | Profile | |
| Amanda Keogh | Gen Marketing | Profile | |
| Ebbe Dommisse | Chief Officer | Profile | |
| Anthony Duncan | CoFounder CEO | Profile | |
| Jason Camp | Chief Officer | Profile | |
| Tone Leivestad | Chief Officer | Profile |
Other Information on Investing in Circa Stock
Circa Group financial ratios help investors to determine whether Circa Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Circa with respect to the benefits of owning Circa Group security.